BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 270 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $48,031 | -24.3% | 445,019 | -12.7% | 0.07% | -17.9% |
Q1 2023 | $63,480 | +27.5% | 509,591 | +53.7% | 0.08% | +23.5% |
Q4 2022 | $49,796 | -99.9% | 331,484 | +38.9% | 0.07% | +61.9% |
Q2 2022 | $35,578,000 | -16.7% | 238,619 | -4.7% | 0.04% | -16.0% |
Q1 2022 | $42,711,000 | -41.9% | 250,419 | -23.8% | 0.05% | -45.7% |
Q2 2021 | $73,570,000 | – | 328,614 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 1,003,640 | $149,643,000 | 20.73% |
Bill & Melinda Gates Foundation | 148,674 | $22,200,000 | 17.06% |
Quinn Opportunity Partners LLC | 300,721 | $44,838,000 | 3.90% |
PARUS FINANCE (UK) Ltd | 42,953 | $6,404,000 | 3.81% |
Renaissance Capital LLC | 36,476 | $5,439,000 | 2.90% |
Baader Bank Aktiengesellschaft | 224,800 | $33,520,000 | 2.58% |
Tri Locum Partners LP | 39,663 | $5,914,000 | 2.42% |
MARK ASSET MANAGEMENT LP | 61,734 | $9,205,000 | 2.22% |
Franchise Capital Ltd | 43,650 | $6,508,000 | 2.18% |
Boston Common Asset Management, LLC | 283,776 | $42,311,000 | 2.11% |